DroneShield is pleased to release the second edition of its Counterdrone Handbook. The publication is a primer for someone new to the counterdrone industry, offering an overview of the industry and the products.
The handbook is free to download and available here
Inovio Pharmaceuticals, Inc.has announced that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical CBRN Defense Consortium will provide $8.14 million to support Inovio in developing a small, portable, battery-powered intradermal device branded as CELLECTRA® 3PSP to be used in the administration of Inovio's vaccines and therapies which include DTRA developed products. In addition to the development of CELLECTRA 3PSP, the new award will fund the investigation of DNA vaccines developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) using the new device.
Telerob Gesellschaft für Fernhantierungstechnik mbH is this year celebrating it's 25th Anniversary. What started as a small sales office for nuclear applications with six employees has developed over the years more and more into the leading supplier of EOD robots. Telerob Gesellschaft für Fernhantierungstechnik mbH can look back proudly on 25 successful years in 2019. Shortly after the company was founded in 1994, the original product range of nuclear technology was expanded to include the field of bomb disposal technology. Telerob quickly specializes in the development of large manipulator vehicles.
Written by Zoe Rutherford on Wednesday, 12 June 2019
Written by Zoe Rutherford on Tuesday, 11 June 2019
Written by Zoe Rutherford on Tuesday, 28 May 2019